Home › Companies › ENFUSION INC. › 2024-2025
At ENFUSION INC.'s shareholder meeting held April 17, 2025, in the 2024-2025 proxy season, 51 asset managers reported how they voted in their SEC Form N-PX filings, covering 261 separate fund positions. Their filings are grouped here into 3 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ENFUSION INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies… — the reporting funds cast 97% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ENFUSION INC.’s Form 8-K, filed April 17, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of April 17, 2025: 1 item on ENFUSION INC.’s Form 8-K, filed April 17, 2025: 1 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025
Explore ENFUSION INC. in the interactive database Compare manager voting policies
These tallies are ENFUSION INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| At the Special Meeting, the Company's stockholders cast their votes for the Proposals, which are described in greater detail in the Proxy Statement, as set forth below. | 99,155,808 | 38,030 | 103,778 | -- | -- | 99.9% | Approved | a majority of the shares outstanding |
Source: ENFUSION INC., Form 8-K, filed with the SEC on April 17, 2025 — read the filing on EDGAR.
Each item below shows how the 51 asset managers that disclosed a ENFUSION INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ENFUSION INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
100% of fund votes cast · no official result
Description as filed by funds: To adopt the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Enfusion, Enfusion Ltd. LLC ("Enfusion OpCo"), Clearwater Analytics Holdings, Inc. ("Clearwater"), Poseidon Acquirer, Inc. ("Acquirer"), Poseidon Merger Sub I, Inc. ("Merger Sub") and Poseidon Merger Sub II, LLC ("Merger Sub II"), pursuant to which (i) Merger Sub II will merge with and into Enfusion OpCo (the "LLC Merger"), with Enfusion OpCo surviving the LLC Merger as an indirect subsidiary of Clearwater, (ii) Merger Sub will merge with and into Enfusion (the "Merger"), with Enfusion surviving the Merger as a direct, wholly-owned subsidiary of Clearwater (the "Surviving Corporation"), and (iii) subject to the satisfaction of certain conditions, the Surviving Corporation will merge with and into Acquirer (the "Second Merger," and, together with the Merger and LLC Merger, the "Mergers"), with Acquirer surviving the Second Merger as a direct, wholly-owned subsidiary of Clearwater, and to approve the Mergers (adoption of the Merger Agreement and approval of the Merger, the "Merger Agreement Proposal").
The 33 asset managers below reported 8,089,477 for, 47,300 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,323,302 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,514,166 | 0 | 0 | 0 | For |
| Fidelity | 1,081,104 | 0 | 0 | 0 | For |
| Dimensional | 619,809 | 0 | 0 | 0 | For |
| MERGER FUND | 343,733 | 0 | 0 | 0 | For |
| State Street | 335,672 | 0 | 0 | 0 | For |
| New York Life | 329,008 | 0 | 0 | 0 | For |
| Equitable | 80,466 | 0 | 47,300 | 0 | Mixed |
| TIAA | 95,288 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 50,720 | 0 | 0 | 0 | For |
| American Century | 46,551 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,300 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,465 | 0 | 0 | 0 | For |
| Northern Trust | 23,047 | 0 | 0 | 0 | For |
| WisdomTree | 21,219 | 0 | 0 | 0 | For |
| Brighthouse | 21,216 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,471 | 0 | 0 | 0 | For |
| Lazard | 20,089 | 0 | 0 | 0 | For |
| Pacific Life | 15,118 | 0 | 0 | 0 | For |
| Voya | 13,765 | 0 | 0 | 0 | For |
| Nationwide | 12,478 | 0 | 0 | 0 | For |
| ProShares | 11,737 | 0 | 0 | 0 | For |
| Prudential/PGIM | 11,590 | 0 | 0 | 0 | For |
| DWS | 7,763 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,513 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To adopt the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Enfusion, Enfusion Ltd. LLC ("Enfusion OpCo"), Clearwater Analytics Holdings, Inc. ("Clearwater"), Poseidon Acquirer, Inc. ("Acquirer"), Poseidon Merger Sub I, Inc. ("Merger Sub") and Poseidon Merger Sub II, LLC ("Merger Sub II"), pursuant to which (i) Merger Sub II will merge with and into Enfusion OpCo (the "LLC Merger"), with Enfusion OpCo surviving the LLC Merger as an ...(due to space limits, see proxy material for full proposal).
The 18 asset managers below reported 4,227,464 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,710,505 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 993,555 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 406,212 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 369,057 | 0 | 0 | 0 | For |
| Charles Schwab | 368,633 | 0 | 0 | 0 | For |
| Nationwide | 129,875 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 84,481 | 0 | 0 | 0 | For |
| Jackson National | 33,661 | 0 | 0 | 0 | For |
| Tidal Trust II | 30,464 | 0 | 0 | 0 | For |
| Global X | 29,471 | 0 | 0 | 0 | For |
| John Hancock | 18,427 | 0 | 0 | 0 | For |
| ALTSHARES TRUST | 17,514 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 10,059 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,778 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 6,008 | 0 | 0 | 0 | For |
| SEI | 4,900 | 0 | 0 | 0 | For |
| Tidal Trust III | 4,445 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 419 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
97% of fund votes cast · no official result
Description as filed by funds: To approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the Merger Agreement Proposal (the "Adjournment Proposal").
The 51 asset managers below reported 11,918,526 for, 398,486 against, 47,300 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,323,302 | 0 | 0 | 0 | For |
| BlackRock | 1,710,505 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,514,166 | 0 | 0 | 0 | For |
| Fidelity | 1,081,104 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 993,555 | 0 | 0 | 0 | For |
| Dimensional | 619,809 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 406,212 | 0 | 0 | 0 | For |
| NEXPOINT FUNDS I | 369,057 | 0 | 0 | 0 | For |
| Charles Schwab | 368,633 | 0 | 0 | 0 | For |
| MERGER FUND | 343,733 | 0 | 0 | 0 | For |
| State Street | 1,157 | 334,515 | 0 | 0 | Against |
| New York Life | 329,008 | 0 | 0 | 0 | For |
| Nationwide | 142,353 | 0 | 0 | 0 | For |
| Equitable | 80,466 | 0 | 47,300 | 0 | Mixed |
| TIAA | 95,288 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 84,481 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 49,020 | 1,700 | 0 | 0 | For |
| American Century | 46,551 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 36,300 | 0 | 0 | Against |
| Jackson National | 33,661 | 0 | 0 | 0 | For |
| Tidal Trust II | 30,464 | 0 | 0 | 0 | For |
| Global X | 29,471 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,465 | 0 | 0 | 0 | For |
| Northern Trust | 23,047 | 0 | 0 | 0 | For |
| WisdomTree | 21,219 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 92,045,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.61% |
| 2 | BlackRock | 1.86% |
| 3 | JANUS INVESTMENT FUND | 1.65% |
| 4 | Fidelity | 1.17% |
| 5 | Brown Capital Management Mutual Funds | 1.08% |
| 6 | Dimensional | 0.67% |
| 7 | ARBITRAGE FUNDS | 0.44% |
| 8 | NEXPOINT FUNDS I | 0.40% |
| 9 | Charles Schwab | 0.40% |
| 10 | MERGER FUND | 0.37% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FTV IV, L.P. | 34.00% | 13D |
| Brown Capital Management, LLC | 5.59% | 13G |
| Vanguard Group | 3.88% | 13F |
| BlackRock | 3.73% | 13F |
| State Street | 1.55% | 13F |
| Geode Capital | 1.19% | 13F |
| Dimensional Fund Advisors | 0.88% | 13F |
| Millennium Management | 0.76% | 13F |
| Northern Trust | 0.47% | 13F |
| Charles Schwab | 0.40% | 13F |
Percentages above are of 92,045,000 shares outstanding, as reported by ENFUSION INC. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ENFUSION INC.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
ENFUSION INC. proxy season coverage: 2024-2025 (this page).
proxyvotesnow.com, “ENFUSION INC. 2025 Special Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/enfusion-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.